Eisler Capital (Us) LLC Gilead Sciences, Inc. Put Options Transaction History

Eisler Capital (Us) LLC

  • $4.03 Trillion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024
BUY
$71.58 - $87.29 $851,802 - $1.04 Million
11,900 Added 21.21%
68,000 $4.98 Billion
Q4 2023

Feb 13, 2024
SELL
$73.27 - $83.09 $1.29 Million - $1.46 Million
-17,600 Reduced 23.88%
56,100 $4.54 Billion
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $5.45 Million - $5.95 Million
73,700 New
73,700 $5.52 Billion

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Eisler Capital (Us) LLC Portfolio

Follow Eisler Capital (Us) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Us) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email